Evidence map›Paper›PMID 37450591›Full record

ArticleScience advances2023

Reversible phase separation of ESCRT protein ALIX through tyrosine phosphorylation.

Ruben D Elias, Yingqi Zhu, Qi Su, Rodolfo Ghirlando, Jin Zhang, Lalit Deshmukh

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ruben D EliasDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA 92093, USA.ORCID 0000-0002-6702-052X
Yingqi ZhuDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA 92093, USA.ORCID 0000-0001-6845-2183
Qi SuDepartment of Pharmacology, University of California, San Diego, La Jolla, CA 92093, USA.
Rodolfo GhirlandoLaboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0003-4880-4959
Jin ZhangDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA 92093, USA.ORCID 0000-0001-7145-7823
Lalit DeshmukhDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA 92093, USA.ORCID 0000-0001-6126-1560
University of California San Diego · USNational Institutes of Health · US

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN JANET LITTLE · 1994 to 2026
$78.4M
X-ray Crystallographic Fragment Screening CoreU54AI150472 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI OLSON, ARTHUR J. · 2019 to 2021
$15.7M
Virus TransmissionP50AI150464 · NIAID · UNIVERSITY OF UTAH · PI HOPE, THOMAS · 2019 to 2021
$14.9M
Live-cell Activity Architecture in CancerR35CA197622 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jin Zhang · 2015 to 2026
$11.2M
Biophysics of Macromolecular ComplexesZIADK033007 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI BUCHANAN, SUSAN · 2009 to 2024
$4.9M
The Functional Interplay Between Phase Separation, Fibrillization, and Posttranslational Modifications of ALIXR35GM147708 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Lalit Deshmukh · 2022 to 2026
$2.0M
JEOL JEM-1400Plus Transmission Electron MicroscopeS10OD023527 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FARQUHAR, MARILYN GIST · 2017 to 2017
$579k
Acquisition of a High Resolution TOF Mass SpectrometerS10RR025636 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MOLINSKI, TADEUSZ F · 2010 to 2010
$305k
NCATS NIH HHS UL1 TR001442NCI NIH HHS R35 CA197622NCRR NIH HHS S10 RR025636NIAID NIH HHS P30 AI036214NIAID NIH HHS P50 AI150464NIAID NIH HHS U54 AI150472NIGMS NIH HHS R35 GM147708NIH HHS S10 OD023527
6 · The paper itself

Abstract

Cytokinetic abscission, the last step of cell division, is regulated by the ESCRT machinery. In response to mitotic errors, ESCRT proteins, namely, ALIX, CHMP4B, and CHMP4C, accumulate in the cytosolic compartments termed "abscission checkpoint bodies" (ACBs) to delay abscission and prevent tumorigenesis. ALIX contributes to the biogenesis and stability of ACBs via an unknown mechanism. We show that ALIX phase separates into nondynamic condensates in vitro and in vivo, mediated by the amyloidogenic portion of its proline-rich domain. ALIX condensates confined CHMP4 paralogs in vitro. These condensates dissolved and reformed upon reversible tyrosine phosphorylation of ALIX, mediated by Src kinase and PTP1B, and sequestration of CHMP4C altered their Src-mediated dissolution. NMR analysis revealed how ALIX triggers the activation of CHMP4 proteins, which is required for successful abscission. These results implicate ALIX's phase separation in the modulation of ACBs. This study also highlights how posttranslational modifications can control protein phase separation.

Indexed as

Cell Cycle ProteinsProtein Processing, Post-TranslationalEndosomal Sorting Complexes Required for TransportPhosphorylationTyrosineCell Cycle ProteinsEndosomal Sorting Complexes Required for TransportTyrosine

Identifiers

PMID37450591
PMCPMC10348681
OpenAlexW4384282639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.